Chemed (NYSE: CHE) has recently received a number of price target changes and ratings updates:
- 10/10/2026 – Chemed was upgraded by Wall Street Zen from “buy” to “strong-buy”.
- 10/8/2026 – Chemed was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
- 9/25/2026 – Chemed is now covered by UBS Group AG. They set a “buy” rating and a $650.00 price target on the stock.
- 9/25/2026 – Chemed is now covered by UBS Group AG. They set a “buy” rating and a $650.00 price target on the stock.
- 9/25/2026 – Chemed is now covered by UBS Group AG. They set a “buy” rating and a $650.00 price target on the stock.
- 9/19/2026 – Chemed was downgraded by Wall Street Zen from “strong-buy” to “buy”.
Chemed Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th were issued a $0.70 dividend. This represents a $2.80 annualized dividend and a yield of 0.5%. This is a boost from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date was Monday, August 17th. Chemed’s dividend payout ratio (DPR) is 14.06%.
Insider Buying and Selling at Chemed
In other Chemed news, Director Patrick Grace sold 190 shares of the company’s stock in a transaction that occurred on Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the transaction, the director owned 3,533 shares in the company, valued at approximately $1,879,556. This represents a 5.10% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Spencer Lee sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $541.04, for a total value of $541,040.00. Following the transaction, the executive vice president owned 13,912 shares in the company, valued at $7,526,948.48. This trade represents a 6.71% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 9,190 shares of company stock valued at $4,833,160. 3.33% of the stock is currently owned by corporate insiders.
Chemed Corporation is a diversified services company headquartered in Cincinnati, Ohio. Its operations are organized through two principal businesses: VITAS Healthcare and Roto-Rooter.
VITAS Healthcare provides hospice and palliative care for patients with advanced illnesses. Its services include clinical care, pain and symptom management, emotional and spiritual support, and assistance for patients and their families in homes, hospice residences, hospitals, nursing facilities, and other care settings.
Featured Stories
- Five stocks we like better than Chemed
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for Chemed Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
